Content about Cancer

October 13, 2011

New research published in the October 2011 issue of Harvard Men's Health Watch suggested aspirin may play a role in fighting cancer, the publication announced Wednesday.

BOSTON — New research published in the October 2011 issue of Harvard Men's Health Watch suggested aspirin may play a role in fighting cancer, the publication announced Wednesday.

October 12, 2011

A National Institutes of Health study published Tuesday in the Journal of the American Medical Association established a link between vitamin E supplementation and prostate cancer.

BETHESDA, Md. — A National Institutes of Health study published Tuesday in the Journal of the American Medical Association established a link between vitamin E supplementation and prostate cancer. Men who took 400 international units of vitamin E daily had more prostate cancers compared with men who took a placebo, according to an updated review of data from the Selenium and Vitamin E Cancer Prevention Trial, the NIH stated.

October 11, 2011

Colomer USA’s ethnic hair care brand Creme of Nature has partnered with Look Good…Feel Better to educate people on the services available for women who are battling cancer and want to enhance their appearance.

JACKSONVILLE, Fla. — Colomer USA’s ethnic hair care brand Creme of Nature has partnered with Look Good…Feel Better to educate people on the services available for women who are battling cancer and want to enhance their appearance.

Throughout October and November, Look Good…Feel Better leaflets can be found inside Creme of Nature product packaging to help spread the word about the organization and the support it provides for women who are undergoing cancer treatment.

October 11, 2011

Drug makers have 901 biotech drugs under development for more than 100 diseases ranging from cancers and infectious diseases to autoimmune disorders and cardiovascular diseases, the Pharmaceutical Research and Manufacturers of America said.


WASHINGTON — Drug makers have 901 biotech drugs under development for more than 100 diseases ranging from cancers and infectious diseases to autoimmune disorders and cardiovascular diseases, the Pharmaceutical Research and Manufacturers of America said.


October 7, 2011

A popular breast cancer treatment may pose an increased risk of diabetes among older women, according to a new study.

NEW YORK — A popular breast cancer treatment may pose an increased risk of diabetes among older women, according to a new study.

The research, which was published in the latest issue of Cancer, found that among more than 14,000 breast cancer survivors, ages 65 years and up, 10% were diagnosed with diabetes over a 5-year period. However, the likelihood of developing diabetes was 25% more among those taking breast cancer drug tamoxifen.

October 5, 2011

The Food and Drug Administration has accepted a regulatory approval application from Merck and Ariad Pharmaceuticals for a new drug to treat soft-tissue and bone cancers, the drug makers said Wednesday.

WHITEHOUSE STATION, N.J. — The Food and Drug Administration has accepted a regulatory approval application from Merck and Ariad Pharmaceuticals for a new drug to treat soft-tissue and bone cancers, the drug makers said Wednesday.

The FDA is expected to complete its review of ridaforolimus for soft-tissue and bone sarcomas in patients who have shown a favorable response to chemotherapy by second quarter 2012.

Sarcomas are cancers of the body's connective tissues, and treatment options remain limited, the companies said.

October 4, 2011

More than three-quarters of cancer patients have insufficient levels of vitamin D, and the lowest levels are associated with more advanced cancer, according to a study presented Oct. 2 at the 53rd Annual Meeting of the American Society for Radiation Oncology.

MIAMI BEACH, Fla. — More than three-quarters of cancer patients have insufficient levels of vitamin D, and the lowest levels are associated with more advanced cancer, according to a study presented Oct. 2 at the 53rd Annual Meeting of the American Society for Radiation Oncology.

September 28, 2011

Sagent Pharmaceuticals has launched its new chemotherapy drug.

SCHAUMBURG, Ill. — Sagent Pharmaceuticals has launched its new chemotherapy drug.

Sagent sent that its paclitaxel injection USP is available in 30-mg, 100-mg and 300-mg latex-free, multi-dose vials. Paclitaxel is indicated for use alone or with other drugs to treat ovarian cancer, breast cancer, non-small cell lung cancer and AIDS-related Kaposi's sarcoma, Sagent said.

September 27, 2011

Mass merchandiser Sam's Club is offering a free women's health screening in recognition of Breast Cancer Awareness Month, the chain said Tuesday.

BENTONVILLE, Ark. — Mass merchandiser Sam's Club is offering a free women's health screening in recognition of Breast Cancer Awareness Month, the chain said Tuesday.

September 27, 2011

A drug made by Eli Lilly prevented the most common form of lung cancer from progressing in elderly patients when added to chemotherapy, according to results of a late-stage clinical trial.

INDIANAPOLIS — A drug made by Eli Lilly prevented the most common form of lung cancer from progressing in elderly patients when added to chemotherapy, according to results of a late-stage clinical trial.

Lilly released results of the 939-patient phase-3 "PARAMOUNT" study, which found that maintenance therapy with the injected drug Alimta (pemetrexed), added to the chemotherapy drug cisplatin, reduced the risk of disease progression in patients ages 70 years and older with advanced nonsquamous no-small cell lung cancer, or NSCLC.

September 26, 2011

Despite flooding from severe weather in several parts of Pennsylvania earlier this month, nearly 600 people ran in their underwear in Philadelphia in support of those who have been affected by colon cancer.

PHILADELPHIA — Despite flooding from severe weather in several parts of Pennsylvania earlier this month, nearly 600 people ran in their underwear in Philadelphia in support of those who have been affected by colon cancer.

Participants of the Fourth Annual Philadelphia Undy 5000 5K Run/Walk ran on MLK Drive, near the Philadelphia Museum of Art, and raised just over $110,000 to fight colon cancer.

September 23, 2011

Researchers have found signaling pathways in cells that may allow earlier detection and prevention of cancer in African-American women.

WASHINGTON — Researchers have found signaling pathways in cells that may allow earlier detection and prevention of cancer in African-American women.

September 21, 2011

Researchers at the University of California Los Angeles said they have found a possible link between two new drugs for Type 2 diabetes and cancers of the pancreas and thyroid, according to a new study published in the journal Gastroenterology.

LOS ANGELES — Researchers at the University of California Los Angeles said they have found a possible link between two new drugs for Type 2 diabetes and cancers of the pancreas and thyroid, according to a new study published in the journal Gastroenterology.

The researchers, at UCLA's Larry L. Hillblom Islet Research Center, examined incidents reported in the Food and Drug Administration's adverse event database between 2004 and 2009 among patients using Byetta (exenatide), made by Eli Lilly and Amylin Pharmaceuticals, and Merck's Januvia (sitagliptin).

September 19, 2011

The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

THOUSAND OAKS, Calif. — The Food and Drug Administration has approved two new uses for a drug made by Amgen, the drug maker said Monday.

Amgen announced the approval of the biotech drug Prolia (denosumab) for increasing bone mass in men and women who are at risk of fractures due to hormone ablation treatments they are receiving for prostate and breast cancer, respectively.

September 16, 2011

Pharmacy benefit manager Express Scripts will provide services for patients using a drug to manage a debilitating side effect of many anti-cancer treatments, ESI said.

ST. LOUIS — Pharmacy benefit manager Express Scripts will provide services for patients using a drug to manage a debilitating side effect of many anti-cancer treatments, ESI said.

September 14, 2011

My Girls Cream (formerly known as My Girls Radiation Cream) is now available at select pharmacies, oncology boutiques and post-surgery specialty retailers, the manufacturer announced on Wednesday.

BOSTON — My Girls Cream (formerly known as My Girls Radiation Cream) is now available at select pharmacies, oncology boutiques and post-surgery specialty retailers, the manufacturer announced on Wednesday.

August 29, 2011

The Food and Drug Administration has approved a new cancer drug made by Pfizer, the drug maker said.

NEW YORK — The Food and Drug Administration has approved a new cancer drug made by Pfizer, the drug maker said.

The FDA approved Pfizer's Xalkori (crizotinib) capsules, a treatment for patients with non-small cell lung cancer that has advanced locally or spread to other parts of the body, also known as metastasis. The drug specifically is designed to target NSCLC containing the enzyme anaplastic lymphoma kinase, as determined by a companion test also approved by the FDA.

August 26, 2011

Increases in vaccination rates for the human papillomavirus are trailing increases in rates for two other vaccines recommended for teens and preteens, according to data from the Centers for Disease Control and Prevention released Thursday.

ATLANTA — Increases in vaccination rates for the human papillomavirus are trailing increases in rates for two other vaccines recommended for teens and preteens, according to data from the Centers for Disease Control and Prevention released Thursday.

Coverage rates for the other two vaccines — Tdap, which protects against tetanus, diphtheria and pertussis; and MenACWY, which protects against meningococcal meningitis — are continuing to increase, but vaccination rates for HPV vaccine remain low, the study found.

August 24, 2011

Temperatures eclipsed 90 degrees Fahrenheit for the second annual Jersey Shore Undy 5000 5-km race held here last month, where Team Dulcolax joined 665 people who turned out to support the colon cancer awareness-raising event.

LONG BRANCH, N.J. — Temperatures eclipsed 90 degrees Fahrenheit for the second annual Jersey Shore Undy 5000 5-km race held here last month, where Team Dulcolax joined 665 people who turned out to support the colon cancer awareness-raising event. All told, participants generated more than $80,000 to help fight colon cancer. 


A portion of the funds raised from the Jersey Shore Undy 5000 will be locally distributed to fund services for those diagnosed with colon cancer.


August 23, 2011

The Food and Drug Administration will decide whether or not to approve a new usage for a cancer drug made by Amgen by next year, the drug maker said.

THOUSAND OAKS, Calif. — The Food and Drug Administration will decide whether or not to approve a new usage for a cancer drug made by Amgen by next year, the drug maker said.

August 19, 2011

A new study published in the Annals of Oncology found that a certain breast cancer drug may pose an increased risk of heart problems in elderly patients with a history of heart disease and/or diabetes.

NEW YORK — A new study published in the Annals of Oncology found that a certain breast cancer drug may pose an increased risk of heart problems in elderly patients with a history of heart disease and/or diabetes.

August 18, 2011

Acai berry, cumin, herbal tea, turmeric and long-term use of garlic may negatively impact chemotherapy treatment, according to a new report released Wednesday that originally was presented at the American Society of Clinical Oncology meeting in Chicago this summer.

CHICAGO — Acai berry, cumin, herbal tea, turmeric and long-term use of garlic may negatively impact chemotherapy treatment, according to a new report released Wednesday that originally was presented at the American Society of Clinical Oncology meeting in Chicago this summer.

Researchers from Northwestern Memorial hospital say there is growing evidence that these popular supplements may intensify or weaken the effect of chemotherapy drugs and in some cases, may cause a toxic, even lethal, reaction.

August 17, 2011

The Food and Drug Administration has approved a new drug and companion diagnostic test for the most dangerous type of skin cancer, the agency said Wednesday.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new drug and companion diagnostic test for the most dangerous type of skin cancer, the agency said Wednesday.

The FDA announced the approval of Genentech's and Daiichi Sankyo's Zelboraf (vemurafenib), for patients with late-stage melanoma that can't be removed by surgery. Genentech is the U.S. division of Swiss drug maker Roche.

August 8, 2011

Specialty pharmacy services company Armada Health Care has enlisted a New York pharmacy professor to assist in the review of developed clinical protocols and medication assessment tools, Armada said Monday.

FLORHAM PARK, N.J. — Specialty pharmacy services company Armada Health Care has enlisted a New York pharmacy professor to assist in the review of developed clinical protocols and medication assessment tools, Armada said Monday.

August 2, 2011

The surgeon general on Monday issued a release promoting breast-feeding in support of World Breast-feeding Week, Aug. 1 through 7.

WASHINGTON — The surgeon general on Monday issued a release promoting breast-feeding in support of World Breast-feeding Week, Aug. 1 through 7.